Wordt geladen...
Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway
Epidemiology and evidence have demonstrated that colon carcinoma is one of the most common gastrointestinal tumors in the clinic. Reports have suggested that Tunicamycin significantly inhibits aggressiveness of colon carcinoma cells by promotion of apoptosis. In the present study, the inhibitory eff...
Bewaard in:
| Gepubliceerd in: | Mol Med Rep |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5802191/ https://ncbi.nlm.nih.gov/pubmed/29344654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2018.8444 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|